X-151396823-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000668689.1(ENSG00000287918):n.320G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000353 in 510,608 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000090 ( 0 hom., 4 hem., cov: 22)
Exomes 𝑓: 0.000020 ( 0 hom. 1 hem. )
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.44
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BS2
High Hemizygotes in GnomAd4 at 4 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VMA21 | NM_001363810.1 | c.-17C>T | 5_prime_UTR_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ENST00000668689.1 | n.320G>A | non_coding_transcript_exon_variant | 1/2 |
Frequencies
GnomAD3 genomes AF: 0.0000896 AC: 10AN: 111656Hom.: 0 Cov.: 22 AF XY: 0.000118 AC XY: 4AN XY: 33832
GnomAD3 genomes
AF:
AC:
10
AN:
111656
Hom.:
Cov.:
22
AF XY:
AC XY:
4
AN XY:
33832
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000671 AC: 6AN: 89404Hom.: 0 AF XY: 0.0000362 AC XY: 1AN XY: 27610
GnomAD3 exomes
AF:
AC:
6
AN:
89404
Hom.:
AF XY:
AC XY:
1
AN XY:
27610
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000201 AC: 8AN: 398903Hom.: 0 Cov.: 0 AF XY: 0.00000700 AC XY: 1AN XY: 142819
GnomAD4 exome
AF:
AC:
8
AN:
398903
Hom.:
Cov.:
0
AF XY:
AC XY:
1
AN XY:
142819
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000895 AC: 10AN: 111705Hom.: 0 Cov.: 22 AF XY: 0.000118 AC XY: 4AN XY: 33891
GnomAD4 genome
AF:
AC:
10
AN:
111705
Hom.:
Cov.:
22
AF XY:
AC XY:
4
AN XY:
33891
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 16, 2023 | Variant summary: VMA21 c.-486C>T is located in the untranscribed region upstream of the VMA21 gene region. The variant allele was found at a frequency of 9e-05 in 110733 control chromosomes (gnomAD v3.1.2). To our knowledge, no occurrence of c.-486C>T in individuals affected with X-Linked Myopathy With Excessive Autophagy and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at